News
PAVM
1.010
-2.88%
-0.030
Weekly Report: what happened at PAVM last week (0708-0712)?
Weekly Report · 4d ago
Weekly Report: what happened at PAVM last week (0701-0705)?
Weekly Report · 07/08 11:08
LUCID DIAGNOSTICS ANNOUNCES POSITIVE DATA FROM ITS ESOGUARD BE-1 PROSPECTIVE, INTERNATIONAL, MULTICENTER CLINICAL VALIDATION STUDY OF ESOGUARD® ESOPHAGEAL PRECANCER TESTING IN A SCREENING POPULATION
Reuters · 07/02 11:55
Weekly Report: what happened at PAVM last week (0624-0628)?
Weekly Report · 07/01 11:09
Weekly Report: what happened at PAVM last week (0617-0621)?
Weekly Report · 06/24 11:16
12 Health Care Stocks Moving In Monday's After-Market Session
ASLAN Pharma (NASDAQ:ASLN) shares moved upwards by 11.9% to $0.4 during Monday's after-market session. China Pharma Holdings, Inc. Common stock increased by 8.68%. CVRx stock rose by 9.48% during the same period. Anitra shares decreased by 21.3% during Monday.
Benzinga · 06/17 20:31
Weekly Report: what happened at PAVM last week (0610-0614)?
Weekly Report · 06/17 11:08
12 Health Care Stocks Moving In Thursday's After-Market Session
Vaxart (NASDAQ:VXRT) shares increased by 146.7% to $1.85 during Thursday's after-market session. Venus Concept stock rose 10.32% and Beyond Air shares moved upwards by 5.64%. Alzamend Neuro stock declined by 24.9% during the session.
Benzinga · 06/13 20:31
PAVMED SUBSIDIARY, VERIS HEALTH, ANNOUNCES LAUNCH OF PILOT PROGRAM WITH THE OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER - JAMES CANCER HOSPITAL AND SOLOVE RESEARCH INSTITUTE
Reuters · 06/13 11:58
Weekly Report: what happened at PAVM last week (0603-0607)?
Weekly Report · 06/10 11:10
PAVmed’s Promising Growth and Market Opportunity Warrant a ‘Buy’ Rating
TipRanks · 06/06 09:55
U.S. RESEARCH ROUNDUP-Chord Energy, PVH, Saia
Wall Street analysts revise ratings and price targets on several U.S.-listed companies. Chord Energy, PVH, Saia and Costco raise their ratings and target prices. Adobe, Campbell Soup and AT&T among companies with target price cuts by Wall Street analysts.
Reuters · 06/06 07:13
PAVMED INC <PAVM.O>: ASCENDIANT CAPITAL MARKETS CUTS TARGET PRICE TO $22 FROM $26
Reuters · 06/06 04:39
Weekly Report: what happened at PAVM last week (0527-0531)?
Weekly Report · 06/03 11:13
Weekly Report: what happened at PAVM last week (0520-0524)?
Weekly Report · 05/27 11:17
Weekly Report: what happened at PAVM last week (0513-0517)?
Weekly Report · 05/20 11:10
Analysts Offer Insights on Healthcare Companies: Mereo Biopharma Group Plc (MREO) and PAVmed (PAVM)
TipRanks · 05/16 12:10
Analysts’ Opinions Are Mixed on These Healthcare Stocks: HUTCHMED (HCM) and PAVmed (PAVM)
TipRanks · 05/15 19:40
PAVmed (PAVM) Receives a Buy from Lake Street
TipRanks · 05/15 13:05
PAVmed Inc Provides Informal Financial Performance Update
TipRanks · 05/14 14:52
More
Webull provides a variety of real-time PAVM stock news. You can receive the latest news about Pavmed through multiple platforms. This information may help you make smarter investment decisions.
About PAVM
PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates through three lines of business: Medical Devices, Diagnostics, and Digital Health. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device for early detection of esophageal precancer to prevent esophageal cancer deaths. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells. EsoGuard is a bisulfite-converted next-generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. Its other subsidiary, Veris Health Inc., is focused on enhanced personalized cancer care through remote patient monitoring using implantable vascular access port with wireless communication combined with an oncologist-designed remote digital healthcare platform.